JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) - Total Assets
Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) holds total assets worth Rs49.69 Billion INR (≈ $537.34 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check total reinvestment intensity of JB Chemicals & Pharmaceuticals Limited to assess the company's total reinvestment commitment from operating cash flow.
JB Chemicals & Pharmaceuticals Limited - Total Assets Trend (2005–2026)
This chart illustrates how JB Chemicals & Pharmaceuticals Limited's total assets have evolved over time, based on quarterly financial data. Explore investment intensity of JB Chemicals & Pharmaceuticals Limited to see how much of total assets are deployed in long-term investments.
JB Chemicals & Pharmaceuticals Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
JB Chemicals & Pharmaceuticals Limited's total assets of Rs49.69 Billion consist of 58.6% current assets and 41.5% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 2.9% |
| Accounts Receivable | Rs7.81 Billion | 15.7% |
| Inventory | Rs6.83 Billion | 13.8% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs12.29 Billion | 24.7% |
| Goodwill | Rs574.60 Million | 1.2% |
Asset Composition Trend (2005–2026)
This chart illustrates how JB Chemicals & Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see JBCHEPHARM stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: JB Chemicals & Pharmaceuticals Limited's current assets represent 58.6% of total assets in 2026, a decrease from 66.5% in 2005.
- Cash Position: Cash and equivalents constituted 2.9% of total assets in 2026, up from 0.0% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 25.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is intangible assets at 24.7% of total assets.
JB Chemicals & Pharmaceuticals Limited Competitors by Total Assets
Key competitors of JB Chemicals & Pharmaceuticals Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
SIMCERE PHARMAC. GRP LTD
F:S2P
|
Germany | €14.73 Billion |
|
Curaleaf Holdings Inc.
TO:CURA
|
Canada | CA$2.88 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥11.13 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
JB Chemicals & Pharmaceuticals Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.92 | 3.04 | 4.50 |
| Quick Ratio | 3.77 | 2.20 | 3.49 |
| Cash Ratio | 0.00 | 0.06 | 0.00 |
| Working Capital | Rs23.18 Billion | Rs12.90 Billion | Rs12.07 Billion |
JB Chemicals & Pharmaceuticals Limited - Advanced Valuation Insights
This section examines the relationship between JB Chemicals & Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.50 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | 16.3% |
| Total Assets | Rs49.69 Billion |
| Market Capitalization | $3.82 Billion USD |
Valuation Analysis
Below Book Valuation: The market values JB Chemicals & Pharmaceuticals Limited's assets below their book value (0.08x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: JB Chemicals & Pharmaceuticals Limited's assets grew by 16.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for JB Chemicals & Pharmaceuticals Limited (2005–2026)
The table below shows the annual total assets of JB Chemicals & Pharmaceuticals Limited from 2005 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs49.69 Billion ≈ $537.34 Million |
+16.26% |
| 2025-03-31 | Rs42.74 Billion ≈ $462.19 Million |
+7.00% |
| 2024-03-31 | Rs39.94 Billion ≈ $431.95 Million |
+12.39% |
| 2023-03-31 | Rs35.54 Billion ≈ $384.34 Million |
+36.30% |
| 2022-03-31 | Rs26.07 Billion ≈ $281.98 Million |
+16.50% |
| 2021-03-31 | Rs22.38 Billion ≈ $242.04 Million |
+23.41% |
| 2020-03-31 | Rs18.14 Billion ≈ $196.13 Million |
+1.26% |
| 2019-03-31 | Rs17.91 Billion ≈ $193.69 Million |
+1.48% |
| 2018-03-31 | Rs17.65 Billion ≈ $190.87 Million |
+5.43% |
| 2017-03-31 | Rs16.74 Billion ≈ $181.04 Million |
+7.49% |
| 2016-03-31 | Rs15.57 Billion ≈ $168.43 Million |
+4.72% |
| 2015-03-31 | Rs14.87 Billion ≈ $160.84 Million |
+10.08% |
| 2014-03-31 | Rs13.51 Billion ≈ $146.11 Million |
+3.91% |
| 2013-03-31 | Rs13.00 Billion ≈ $140.61 Million |
+8.55% |
| 2012-03-31 | Rs11.98 Billion ≈ $129.54 Million |
+19.85% |
| 2011-03-31 | Rs9.99 Billion ≈ $108.08 Million |
+19.40% |
| 2010-03-31 | Rs8.37 Billion ≈ $90.51 Million |
+12.15% |
| 2009-03-31 | Rs7.46 Billion ≈ $80.71 Million |
+0.68% |
| 2008-03-31 | Rs7.41 Billion ≈ $80.17 Million |
+4.07% |
| 2007-03-31 | Rs7.12 Billion ≈ $77.03 Million |
+40.97% |
| 2006-03-31 | Rs5.05 Billion ≈ $54.64 Million |
+22.85% |
| 2005-03-31 | Rs4.11 Billion ≈ $44.48 Million |
-- |
About JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dos… Read more